Prone Breast Irradiation for Pendulous Breasts
- Conditions
- Breast Cancer
- Interventions
- Device: Mamma board
- Registration Number
- NCT00181363
- Lead Sponsor
- Maastricht Radiation Oncology
- Brief Summary
We hypothesize that for large pendulous breasts, breast irradiation in supine and prone position are equivalent with regard to coverage of the PTV, but with a better dose homogeneity in prone position and a smaller radiation exposure of lung and heart.The purpose of this study is to compare the 3-D dose distribution in PTV(Planning Target Volume) and normal tissues in prone position versus supine position.
- Detailed Description
Local excision followed by adjuvant radiotherapy has become standard treatment for women with early-stage breast cancer. Adjuvant radiotherapy may encounter technical difficulties in patients with pendulous breasts when treated in supine position.
Based upon literature and our own preliminary experiences, we hypothesize that for large pendulous breasts, breast irradiation in supine and prone position are equivalent with regard to coverage of the PTV, but with a better dose homogeneity in prone position and a smaller radiation exposure of lung and heart. However, no quantitative data are yet available to test this hypothesis. Therefore, the aim of our study is to compare the 3-D dose distribution in PTV and normal tissues in prone position versus supine position. For treatment in prone-position an in-house developed device, the "mammaboard" was used.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 10
- Patients should have had breast-conserving surgery for breast cancer or DCIS (Ductal Carcinoma in Situ)
- No indication for radiotherapy of regional nodes
- Large, pendulous breasts (bra size D and over)
- Regional radiotherapy is indicated
- Unable to lie in prone position
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Mamma board Mamma board use of the mamma board during radiotherapy
- Primary Outcome Measures
Name Time Method Dose Homogeneity 1: PTV 1 day after treatment planning Quantitatively compare the 3 D dose distribution in the PTV (Planning Target Volume) and normal tissues in prone position versus supine position
Dose Homogeneity 3: V95 % 1 day after treatment planning PTV coverage (% of PTV \< 95% of prescribed dose) in prone position versus supine position
Dose Homogeneity 2: V105% and V107% 1 day after treatment planning Quantitatively compare the 3 D dose distribution in the PTV (Planning Target Volume) in prone position versus supine position
- Secondary Outcome Measures
Name Time Method PTV Coverage in Organs at Risk: Heart V30 during treatment planning Doses in organs at risk: heart V30: the volumes (%) of the heart that received \>= 30Gy
PTV Coverage in Organs at Risk: MLD (Gy) during treatment planning Doses in organs at risk: lung MLD (Mean Lung Dose)
Trial Locations
- Locations (1)
Maastricht Radiation Oncology
🇳🇱Heerlen, Limburg, Netherlands